What are the specific molecular mechanisms by which AQP4 dysfunction contributes to CNS disorder pathogenesis?

PARTIALLY ADDRESSED

The abstract states that AQP4 'is part of the pathogenesis' of CNS disorders and shows 'notable variability' in these conditions, but the precise causal mechanisms linking AQP4 alterations to disease development remain unexplained. Understanding these mechanisms is critical for developing AQP4-targeted therapeutics. Gap type: unexplained_observation Source paper: Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. (2023, Neurobiol Dis, PMID:36796590)

Priority: 0.80 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What are the specific molecular mechanisms by which AQP4 dysfunction contributes to CNS disorder pathogenesis? is a 0.8 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What are the specific molecular mechanisms by which AQP4 dysfunction contributes to CNS disorder pathogenesis? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (1)

AQP4COMPLEMENT CASCADE

associated with (5)

AQP4CSF-ISF ExchangeAQP4Glymphatic SystemAQP4Sepsis-Associated EncephalopathyAQP4Neuromyelitis Optica Spectrum DisorderAQP4NEUROMYELITIS OPTICA SPECTRUM DISORDER

binds (5)

AQP4Aquaporin-4-IgGcalmodulinAQP4IGG AUTOANTIBODYAQP4AQP4-ANTIBODYAQP4AQP4-AbAQP4

biomarker for (4)

AQP4Neuromyelitis OpticaAQP4NEUROMYELITIS OPTICA SPECTRUM DISORDERAQP4NMOSDAQP4Neuromyelitis Optica Spectrum Disorder

component of (2)

AQP4Glymphatic PathwayAQP4Glymphatic System

data in (1)

ds-f2c28aed24a7AQP4

describes (1)

cell-types-nodes-ranvier-neurodCNS

detects glymphatic dysfunction (1)

H5_AQP4AQP4

encodes (1)

AQP4AQP4

enhances function (1)

H2AQP4

expressed in (3)

AQP4Astrocytic EndfeetAQP4Astrocyte EndfeetAQP4Central Nervous System

implicated in (1)

AQP4demyelination

inhibits (2)

AQP4NF-κB PathwayAQP4Astrocytic Autophagy

involved in (5)

AQP4CNS edemaAQP4Glymphatic PathwayAQP4Glymphatic DysfunctionAQP4GLYMPHATIC SYSTEMAQP4Beta-Amyloid Clearance

mediates (8)

AQP4glymphatic pathwayAQP4Perivascular Water TransportAQP4CSF-ISF ExchangeAQP4Glymphatic ClearanceAQP4Glymphatic Transport
▸ Show 3 more

promotes (1)

AQP4brain edema

protects against (1)

AQP4Tau Aggregation

provides data for (1)

AQP4ds-f2c28aed24a7

regulates (4)

AQP4Tau ClearanceAQP4Amyloid Beta ClearanceAQP4CHI3L1B CellsAQP4

targets (1)

TGN-020AQP4

upregulates (1)

Cecal Ligation and PerforationAQP4
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps